In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Becton, Dickinson and Company

https://www.bd.com/en-us

Latest From Becton, Dickinson and Company

Asia Deal Watch: Biocytogen Antibody Candidates To Be Evaluated By ADC Therapeutics

Transactions involving Biocon/Zentiva, CrystalGenomics/PanGen, Umoja/IASO, Marinus/Tenacia, Ono/Captor and Daewoong/HitGen plus deals in brief.

Deal Watch Business Strategies

The Busiest Dealmakers Of 2022

With only weeks to go in 2022, the three major pharmas each had inked between 16 and 20 deals. Meanwhile, Pfizer has been less busy with 12 deals, but those include M&A totaling $18.2bn.

Outlook 2023 M & A

Full-Life Expands Radiopharmaceutical Reach With $245m Focus-X Buyout

Full-Life’s acquisition of Focus-X came after two other Chinese biotechs leaped into the fray for a leading position in China’s nascent radionuclide therapy market.

China M & A

US FDA Guidance Aims To Tackle Challenges In Multi-Endpoint Trials

Final guidance targets the ‘multiplicity problem.’ At about half the length of the 2017 draft, the final removes some sections, truncates other and drops several examples.

Clinical Trials Guidance Documents
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
  • Medical Devices
    • Diagnostic Equipment & Supplies
    • Implantable Devices
  • Biotechnology
    • Drug Discovery Tools
  • Other Names / Subsidiaries
    • BD
    • BD Medical
    • Bridger Biomed, Inc.
    • Caesarea Medical Electronics
    • CareFusion
    • Carmel Pharma, Inc.
    • Carmel Pharma, AB
    • Cellular Research, Inc.
    • C.R. Bard, Inc.
    • CRISI Medical Systems
    • Davol, Inc.
    • Embo Medical Limited
    • FlowCardia, Inc.
    • GenCell Biosystems, Ltd.
    • GeneOhm Sciences
    • Liberator Medical, Inc.
    • Lutonix, Inc.
    • Medafor, Inc.
    • Medicon, Inc.
    • Neomend, Inc.
    • Sirigen Group Limited
    • TriPath Imaging
    • TVA Medical, Inc.
    • Rochester Medical, Inc.
    • Safety Syringes Inc.
    • Vascular Pathways, Inc.
    • Venclose, Inc.
UsernamePublicRestriction

Register